| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3958 | 1998 |
| Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ... New England Journal of Medicine 346 (21), 1616-1622, 2002 | 1862 | 2002 |
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ... Jama 304 (9), 967-975, 2010 | 1672 | 2010 |
| Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L Van’t Veer, ... Journal of clinical oncology 22 (6), 1055-1062, 2004 | 1515 | 2004 |
| Metabolic gene polymorphism frequencies in control populations S Garte, L Gaspari, AK Alexandrie, C Ambrosone, H Autrup, JL Autrup, ... Cancer Epidemiology Biomarkers & Prevention 10 (12), 1239-1248, 2001 | 1132 | 2001 |
| Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers TR Rebbeck, ND Kauff, SM Domchek Journal of the National Cancer Institute 101 (2), 80-87, 2009 | 1120 | 2009 |
| Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. TR Rebbeck Cancer epidemiology, biomarkers & prevention: a publication of the American …, 1997 | 1074 | 1997 |
| Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program MS Brose, TR Rebbeck, KA Calzone, JE Stopfer, KL Nathanson, ... Journal of the National Cancer Institute 94 (18), 1365-1372, 2002 | 966 | 2002 |
| BRCA1 Mutations in Women Attending Clinics That Evaluate the Risk of Breast Cancer FJ Couch, ML DeShano, MA Blackwood, K Calzone, J Stopfer, ... New England Journal of Medicine 336 (20), 1409-1415, 1997 | 940 | 1997 |
| Type I and II endometrial cancers: have they different risk factors? VW Setiawan, HP Yang, MC Pike, SE McCann, H Yu, YB Xiang, A Wolk, ... Journal of Clinical Oncology 31 (20), 2607, 2013 | 904 | 2013 |
| Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers TR Rebbeck, AM Levin, A Eisen, C Snyder, P Watson, L Cannon-Albright, ... Journal of the National Cancer Institute 91 (17), 1475-1479, 1999 | 839 | 1999 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 756 | 2012 |
| Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study ND Kauff, SM Domchek, TM Friebel, ME Robson, J Lee, JE Garber, ... Journal of clinical oncology 26 (8), 1331, 2008 | 706 | 2008 |
| Comprehensive genomic characterization of long non-coding RNAs across human cancers X Yan, Z Hu, Y Feng, X Hu, J Yuan, SD Zhao, Y Zhang, L Yang, W Shan, ... Cancer cell 28 (4), 529-540, 2015 | 646 | 2015 |
| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 644 | 2013 |
| Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 TR Rebbeck, JM Jaffe, AH Walker, AJ Wein, SB Malkowicz JNCI: Journal of the National Cancer Institute 90 (16), 1225-1229, 1998 | 638 | 1998 |
| Assessment of cumulative evidence on genetic associations: interim guidelines JPA Ioannidis, P Boffetta, J Little, TR O’Brien, AG Uitterlinden, P Vineis, ... International journal of epidemiology 37 (1), 120-132, 2008 | 629 | 2008 |
| Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities RB Warnecke, A Oh, N Breen, S Gehlert, E Paskett, KL Tucker, N Lurie, ... American journal of public health 98 (9), 1608-1615, 2008 | 582 | 2008 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 546 | 2015 |
| Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study … TR Rebbeck, T Friebel, T Wagner, HT Lynch, JE Garber, MB Daly, ... Journal of clinical oncology 23 (31), 7804-7810, 2005 | 538 | 2005 |
